Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Nicole Heather Moraco, M.D.

Concepts (101)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Sarcoma7201618880.360 Why?
Physicians1202345390.250 Why?
Neoplasms, Radiation-Induced320135450.230 Why?
Retroperitoneal Neoplasms220163340.190 Why?
Neoplasm Recurrence, Local8201691220.180 Why?
Nerve Sheath Neoplasms220121900.170 Why?
Health Care Rationing120224390.160 Why?
Standard of Care120225630.160 Why?
Neoplasms, Second Primary2201310450.120 Why?
Hemangiosarcoma220132280.120 Why?
Nomograms120152230.110 Why?
Residence Characteristics1202220410.100 Why?
Thoracic Wall120132010.100 Why?
Leiomyosarcoma220134690.100 Why?
Communication1202337220.080 Why?
Liposarcoma120113240.080 Why?
Quality Improvement1202337300.080 Why?
Neurofibromatosis 1120125580.070 Why?
Radiotherapy2201115260.070 Why?
Neoplasm Staging32015109610.060 Why?
Soft Tissue Neoplasms1201313590.060 Why?
Pandemics1202382740.050 Why?
Disease-Free Survival4201568710.050 Why?
Lymphoma1201118730.050 Why?
Head and Neck Neoplasms1201527060.050 Why?
Bone Neoplasms1201325210.050 Why?
Survival Rate42016127610.040 Why?
Health Priorities120223800.040 Why?
Neoplasm, Residual220139700.040 Why?
Radiotherapy, Adjuvant2201317710.040 Why?
Liver Neoplasms1201342160.040 Why?
Vulnerable Populations120226850.030 Why?
Prognosis52016289010.030 Why?
Kaplan-Meier Estimate3201265160.030 Why?
Middle Aged1220222128630.030 Why?
United States12023695730.030 Why?
Aged1020221626980.030 Why?
Viscera120141390.030 Why?
Humans1420237393980.030 Why?
Aged, 80 and over62013576500.030 Why?
Follow-Up Studies42016389420.020 Why?
Female1220223788530.020 Why?
Male1120223490220.020 Why?
DNA Topoisomerases, Type II120111210.020 Why?
Dermatofibrosarcoma12010620.020 Why?
Tumor Burden1201619040.020 Why?
Histiocytoma, Malignant Fibrous12010630.020 Why?
Combined Modality Therapy2201386050.020 Why?
Antineoplastic Combined Chemotherapy Protocols12010114100.020 Why?
Adult920142133940.020 Why?
Retrospective Studies52022766310.020 Why?
Critical Care1202226240.020 Why?
Boston1202293140.020 Why?
New York City120117040.020 Why?
Multivariate Analysis22013122370.020 Why?
Young Adult52013562550.020 Why?
Lung Neoplasms12013129850.020 Why?
Fibrosarcoma120103480.020 Why?
Extremities120138490.020 Why?
Adolescent52013854050.020 Why?
Proportional Hazards Models22012123280.020 Why?
Healthcare Disparities1202231380.020 Why?
Statistics, Nonparametric1201228810.020 Why?
Confidence Intervals1201229740.020 Why?
Lower Extremity1201411450.020 Why?
Breast Neoplasms12013206760.020 Why?
Gene Knockdown Techniques1201116540.020 Why?
Medical Records1201114130.020 Why?
Lymphatic Metastasis1201328970.020 Why?
Incidence22016209130.020 Why?
Prospective Studies32016530370.020 Why?
Cell Adhesion Molecules1201115990.020 Why?
Severity of Illness Index12022155110.010 Why?
Chemotherapy, Adjuvant1201234530.010 Why?
Radiotherapy Dosage1201028720.010 Why?
Protein Kinases1201116370.010 Why?
Receptor Protein-Tyrosine Kinases1201116590.010 Why?
Antigens, Neoplasm1201119770.010 Why?
Hospitalization12022102080.010 Why?
Oligonucleotide Array Sequence Analysis1201139220.010 Why?
Risk Assessment22016232940.010 Why?
Neoplasm Metastasis1201248320.010 Why?
Up-Regulation1201142050.010 Why?
RNA, Small Interfering1201134980.010 Why?
Neoadjuvant Therapy1201226880.010 Why?
Risk Factors32013719740.010 Why?
Survivors1201122800.010 Why?
Survival Analysis12013102470.010 Why?
Databases, Factual1201476900.010 Why?
Age Factors12016183490.010 Why?
Muscle, Skeletal1201349200.010 Why?
Treatment Outcome22013626930.010 Why?
Predictive Value of Tests12011150360.010 Why?
Gene Expression Profiling1201193870.010 Why?
Apoptosis1201197140.010 Why?
Cell Line, Tumor12011166460.010 Why?
Prevalence12011151530.010 Why?
DNA-Binding Proteins1201196220.010 Why?
Genetic Predisposition to Disease12011173840.010 Why?
Time Factors12010400500.000 Why?
Cohort Studies12011403890.000 Why?
Moraco's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (101)
Explore
_
Co-Authors (9)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.